Skip to main content
. 2020 Jul 1;43(9):2074–2081. doi: 10.2337/dc19-1571

Figure 1.

Figure 1

Adjusted Cox survival curves: time from baseline elevated HbA1c measurement around the ACA expansion to a controlled measurement by insurance cohort. This subset analysis identified patients with an uncontrolled HbA1c (HbA1c ≥9%) measurement within 3 months prior to ACA Medicaid expansion start date (1 January 2014). We followed these patients 24 months post–Medicaid expansion until their time to a controlled measurement (<9% HbA1c). Ref, reference.